Investors

banner

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Clinical Study using QuantaFlo® published in Peer-Reviewed Journal of Vascular Surgery
Results show a positive screening of previously undetected PAD was independently associated with short-term and long-term increased risks for mortality and major adverse cardiovascular events SANTA CLARA, Calif. , March 1, 2022 /PRNewswire/ --  Semler Scientific, Inc.
View HTML
Toggle Summary Semler Reports First Quarter 2017 Financial Results
Inventory and Manufacturing Capacity Grow to Prepare for Larger Orders
View HTML
Toggle Summary Semler Reports First Quarter 2018 Financial Results
Profitability Continues SAN JOSE, Calif. , May 1, 2018 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), an emerging growth company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today reported financial results for the three
View HTML
Toggle Summary Semler Reports First Quarter 2019 Financial Results
2019 Q1 HIGHLIGHTS compared to the corresponding period of 2018: - Revenue was $6,761,000, which is an increase of 51% - Net income grew to $0.29 per basic share and $0.23 per diluted share, compared to $0.12 per basic and 0.10 per diluted share - Cash at March 31, 2019 increased to $4,544,000 from
View HTML
Toggle Summary Semler Reports First Quarter 2020 Financial Results
2020 Q1 HIGHLIGHTS compared to the corresponding period of 2019: - Revenues were $9,430,000, which is an increase of 39% - Pre-tax net income of $3,450,000, an increase of $1,596,000, or 86%, compared to $1,854,000 - Net income grew to $0.41 per basic share and $0.33 per diluted share, compared to
View HTML
Toggle Summary Semler Reports First Quarter 2021 Financial Results
2021 Q1 HIGHLIGHTS compared to the corresponding period of 2020: - Revenues were $13.2 million, an increase of 40% - Pre-tax net income of $6.0 million, an increase of $2.5 million, or 74%, compared to $3.5 million - Net income was $4.9 million, or $0.73 per basic share and $0.60 per diluted share,
View HTML
Toggle Summary Semler Reports First Quarter 2022 Financial Results
2022 Q1 HIGHLIGHTS   compared to the corresponding period of 2021: Revenues were $14.0 million , an increase of $0.8 million , or 6%, compared to $13.2 million Net income was $3.4 million , or $0.50 per basic share and $0.41 per diluted share, compared to $4.9 million , or $0.73 per basic share and
View HTML
Toggle Summary Semler Reports Fourth Quarter and Annual 2016 Financial Results
Continuing to Increase Market Penetration of its QuantaFlo™ product
View HTML
Toggle Summary Semler Reports Fourth Quarter and Year End 2018 Financial Results
2018 HIGHLIGHTS compared to 2017: - Annual revenue increased by 73% - Net income after tax grew to $0.82 per basic share and $0.66 per diluted share, compared to a net loss of $0.28 per basic and diluted share - All principal and accrued interest on notes were retired - Cash at year-end increased
View HTML
Toggle Summary Semler Reports Fourth Quarter and Year-to-Date 2021 Financial Results
2021 HIGHLIGHTS compared to 2020: -- Annual revenues increased by 37% -- Net income increased by 23% -- Cash at December 31, 2021 increased to $37.3 million from $22.1 million SANTA CLARA, Calif. , Feb. 28, 2022 /PRNewswire/ -- Semler Scientific, Inc.
View HTML

Semler Scientific

Contact us
Semler Scientific, Inc.
2344 Walsh Avenue
Santa Clara, CA 95051

Call us toll-free at
877-774-4211